已收盤 01-09 16:00:00 美东时间
-1.260
-0.87%
今日重点评级关注:HC Wainwright & Co.:维持奥麦罗制药"买入"评级,目标价从20美元升至40美元;HC Wainwright & Co.:维持Cullinan Therapeutics"买入"评级,目标价从26美元升至27美元
01-09 20:22
今日重点评级关注:HC Wainwright & Co.:维持Assertio Holdings"买入"评级,目标价从3美元升至35美元;HC Wainwright & Co.:维持万达生物制药"买入"评级,目标价从20美元升至22美元
01-06 17:52
Bernstein analyst Zhihan Ma maintains Dollar General (NYSE:DG) with a Outperform and raises the price target from $141 to $150.
01-05 21:48
Dollar General (DG) momentum hits 89.60 ahead of the Jan 6 ex-dividend date. See why the stock is surging following a strong Q3 earnings beat.
01-05 20:13
2025 was a rollercoaster for Benzinga chat room participants, with mixed opinions on various stocks; 2026 may see escalation of China/Taiwan issue.
01-01 05:06
高收入家庭维持高端消费,而中低收入群体更倾向性价比,利好沃尔玛(WMT)、TJX(TJX)、Dollar General(DG)和Dollar Tree(...
2025-12-26 23:35
今日重点评级关注:Truist Securities:维持拜玛林制药"买入"评级,目标价从80美元升至100美元;HC Wainwright & Co.:维持Savara"买入"评级,目标价从8美元升至10美元
2025-12-24 11:17
Evercore ISI Group analyst Michael Montani maintains Dollar General (NYSE:DG) with a In-Line and raises the price target from $130 to $135.
2025-12-23 21:53
今日重点评级关注:HC Wainwright & Co.:维持Pyxis Oncology"买入"评级,目标价从5美元升至7美元;Stifel:维持Oculis Holding"买入"评级,目标价从35美元升至40美元
2025-12-22 15:05
今日重点评级关注:HC Wainwright & Co.:维持BioCryst Pharma"买入"评级,目标价从30美元升至32美元;TD Cowen:上调Milestone Pharmaceuticals评级至"买入",目标价8美元
2025-12-16 09:36